Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Hikma Pharms Plc ADR (HKMPY)

Hikma Pharms Plc ADR (HKMPY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma PR Newswire - Thu Jun 4, 4:39PM CDT

LONDON , June 4, 2026 /PRNewswire/ -- Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc., (Hikma) offered the following comments on today's unanimous...

HKMPY : 44.2500 (+7.38%)
Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US PR Newswire - Mon Dec 8, 2025

Ready-to-use sepsis therapy marks new advancement in time-critical treatment

HKMPY : 44.2500 (+7.38%)
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg GlobeNewswire - Thu Mar 20, 2025

HIK.LN : 1,629.000 (-0.18%)
EBS : 8.14 (-1.81%)
HKMPY : 44.2500 (+7.38%)

Barchart Exclusives

Nike’s Dividend Yield Is Near Record Highs, But That’s Not a Good Enough Reason to Buy NKE Stock Barchart - Wed Jul 8, 6:30PM CDT
Nike's dividend yield is nearly 3.8%, which is near the record highs we saw last month. That, however, does not make the stock a buy. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.